Paris — Cellectis bioresearch, a specialist in genome customization and a subsidiary of Cellectis S.A. (Alternext: ALCLS), has today announced the launch of cGPS® Custom HEK293, its first research kit that can be used on cell lines derived from human material.

The new cGPS® Custom kit will allow scientists to control the expression of any gene of interest in the human embryonic kidney cell line, HEK293. Specifically, the kit allows rapid, efficient and precise gene integration and expression, enabling high quality research into the mechanisms of human gene function and its involvement in disease.

The cGPS® Custom HEK293 kit has been initially validated in HEK293 cells, however it also has the potential to be used in any cell line derived from human material. During 2010 Cellectis will focus on expanding its series of ready-to-use products for the functional genetics market by validating cGPS® Custom HEK293, and its associated simple operating protocols, in other human cell lines.

“We are very excited to reach our goal of launching six new bioresearch kits this year,” said Luc Selig, VP Sales & Marketing for Cellectis bioresearch. “We are looking forward to bringing a wider range of kits to the market next year”.

Cellectis bioresearch currently supplies two targeted integration product lines – cGPS® (cellular Genome Positioning System) and cGPS® Custom – both of which can be purchased via www.cellectis-bioresearch.com.